Cognitive Impairment Disorders Drug Development Pipeline Review, 2018
- Pages: 376
- Published: January 2018
- Report Code: GBIHC029IDB
This report provides an overview of the pipeline landscape for cognitive impairment disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for cognitive impairment associated with schizophrenia (CIAS), dementia, mild cognitive impairment and Alzheimer’s disease, and features dormant and discontinued products.
These disorders are associated with impairments in cognitive abilities such as learning, memory and perception. Due to the complex and highly sophisticated nature of the central nervous system (CNS), the pathophysiology of these disorders is not well understood and treatment options remain limited. Currently, marketed drugs act by slowing disease progression or treating symptoms.
Worldwide, the burden of cognitive impairment disorders will increase significantly in the coming decades due to aging populations. Consequently, there is a strong need to develop new therapies that effectively treat symptoms and target underlying mechanisms of disease.
Scope
– Which companies are the most active within the pipeline for cognitive impairment disorders?
– Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
– To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
– What are the most important R&D milestones and data publications to have happened within this field?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Companies mentioned
AB Science SA
AbbVie Inc
AC Immune SA
Acadia Pharmaceuticals Inc
Accera Inc
Acorda Therapeutics Inc
Actinogen Medical Ltd
Acumen Pharmaceuticals Inc
Adamas Pharmaceuticals Inc
Addex Therapeutics Ltd
Aequus Pharmaceuticals Inc
AFFiRiS AG
AgeneBio Inc
Alector LLC
Allergan Plc
Allgenesis Biotherapeutics Inc
Allinky Biopharma
ALSP Inc
Alzhyme Pty Ltd
Alzinova AB
AlzProtect SAS
Amarantus Bioscience Holdings Inc
Amgen Inc
Anavex Life Sciences Corp
Annexon Inc
Aphios Corp
Apodemus AB
Applied Research using OMIC Sciences SL
Aptevo Therapeutics Inc
Araclon Biotech SL
Archer Pharmaceuticals Inc
ArmaGen Inc
Asceneuron SA
Astellas Pharma Inc
AstraZeneca Plc
Aucta Pharmaceuticals LLC
Avineuro Pharmaceuticals Inc
Avraham Pharmaceuticals Ltd
Axon Neuroscience SE
Axovant Sciences Ltd
Axsome Therapeutics Inc
Axxam SpA
AZTherapies Inc
Beactica AB
Berg LLC
BioArctic AB
Biogen Inc
Biohaven Pharmaceutical Holding Company Ltd
BioHealthonomics Inc
Boehringer Ingelheim GmbH
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Bsim2
Cadent Therapeutics
Cantabio Pharmaceuticals Inc
Cardax Inc
Carna Biosciences Inc
Celon Pharma SA
CereSpir Inc
CHA Bio & Diostech Co Ltd
Clera Inc
Cognition Therapeutics Inc
Cognosci Inc
CohBar Inc
Connexios Life Sciences Pvt Ltd
ConSynance Therapeutics Inc
Corium International Inc
Coronis NeuroSciences Ltd
Cortice Biosciences Inc
Cotinga Pharmaceuticals Inc
Crossbeta Biosciences BV
Cypralis Ltd
Daewoong Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Daval International Ltd
Denali Therapeutics Inc
Diffusion Pharmaceuticals Inc
Dongkook Pharmaceutical Co Ltd
Dr. August Wolff GmbH & Co KG Arzneimittel
Echo Pharmaceuticals BV
Eisai Co Ltd
Eli Lilly and Co
Endece LLC
Ensemble Therapeutics Corp
Epigen Biosciences Inc
Evotec AG
F. Hoffmann-La Roche Ltd
Genentech Inc
Genervon Biopharmaceuticals LLC
Genzyme Corp
GlaxoSmithKline Plc
GliaCure Inc
Glialogix Inc
Golden Biotechnology Corp
Grifols SA
H. Lundbeck AS
Hemostemix Inc
Heptares Therapeutics Ltd
HitGen LTD
Hyundai Pharmaceutical Co Ltd
ICB International Inc
Ichor Medical Systems Inc
Icure Pharmaceutical Inc
ID Pharma Co Ltd
Ildong Pharmaceutical Co Ltd
Immungenetics AG
Immunwork Inc
Impel NeuroPharma Inc
India Globalization Capital Inc
Insys Therapeutics Inc
IntelGenx Corp
Intellect Neurosciences Inc
Intra-Cellular Therapies Inc
Io Therapeutics Inc
Ionis Pharmaceuticals Inc
Iproteos SL
IRLAB Therapeutics AB
Ironwood Pharmaceuticals Inc
Jeil Pharmaceutical Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Johnson & Johnson
Kadmon Corp LLC
Karuna Pharmaceuticals Inc
Krenitsky Pharmaceuticals Inc
K-Stemcell Co Ltd
Kyowa Hakko Kirin Co Ltd
Lead Discovery Center GmbH
Les Laboratoires Servier SAS
Lipopharma Therapeutics SL
Living Cell Technologies Ltd
Lupin Ltd
M3 Biotechnology Inc
ManRos Therapeutics
MedDay SA
Medesis Pharma SA
MedImmune LLC
MediPost Co Ltd
MEDRx Co Ltd
MEI Pharma Inc
Merck & Co Inc
Microlin Bio Inc
MindImmune Therapeutics Inc
Mitsubishi Tanabe Pharma Corp
ModGene Pharma LLC
Montisera Ltd
NAL Pharmaceuticals Ltd
Nanomerics Ltd
NeoNeuro SAS
Neuraltus Pharmaceuticals Inc
Neurim Pharmaceuticals Ltd
Neurimmune Holding AG
Neuro Bio Ltd
NeuroGenetic Pharmaceuticals Inc
Neuron Biopharma SA
NeuroNascent Inc
NeurOp Inc
Neuropore Therapies Inc
Neuro-Sys SAS
Neurotez Inc
New World Laboratories Inc
NoNO Inc
Novartis AG
Nymox Pharmaceutical Corp
Octapharma AG
Oryzon Genomics SA
Otsuka Holdings Co Ltd
Ovensa Inc
Oxstem Ltd
P2D Bioscience
Pacific Northwest Biotechnology LLC
Pain Therapeutics Inc
Peptron Inc
Pfizer Inc
Pharmasum Therapeutics AS
Pharmaxis Ltd
Pharnext SA
Phoenix Biotechnology Inc
Prana Biotechnology Ltd
Prevacus Inc
Priavoid GmbH
Probiodrug AG
Progenra Inc
ProMIS Neurosciences Inc
ProQR Therapeutics NV
Proteome Sciences Plc
Proteostasis Therapeutics Inc
Sage Therapeutics Inc
Saniona AB
SBI Pharmaceuticals Co Ltd
Sinil Pharmaceutical Co Ltd
Spherium Biomed SL
Stemedica Cell Technologies Inc
Sumitomo Dainippon Pharma Co Ltd
Suven Life Sciences Ltd
Takeda Pharmaceutical Co Ltd
TauRx Therapeutics Ltd
Theranexus SAS
Therapix Biosciences Ltd
Vanda Pharmaceuticals Inc
Vicore Pharma AB
Voyager Therapeutics Inc
WAVE Life Sciences Ltd
WhanIn Pharmaceutical Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.